CRO

History of InCROM Group

InCROM Group consisting of CRO, SMO and site network services started our full-scale clinical trial support services in 1983. Founded in 1975 as RABITON Farm and later incorporated as RABITON Institute, Inc., we evolved from rabbit farming to non-clinical research supporting the conduct of non-clinical studies such as reproductive toxicity studies, and ocular mucosa and skin irritation studies in rabbits. In 1983, we also supported the establishment of Osaka Pharmacology Research Clinic, a facility specialized in clinical trials. As part of the InCROM Group affiliated clinical trial site network, together with Heishinkai Medical Corporation and other core affiliates, and InCROM SMO, InCROM CRO (incorporated in 2010) provides clinical trial support services across a wide array of indications.

InCROM CRO

Being part of the InCROM Group, InCROM CRO leverages on the group resources and collaborations with InCROM (SMO) and affiliate Heishinkai Medical Corporation (Heishinkai) to offer our clients synergies leading to clinical conduct efficiency enhancement. Both InCROM (SMO) and Heishinkai have a wealth of experience and knowledge in clinical pharmacology, allowing us to provide high quality CRO services on tasks such as clinical trial planning consultation, protocol development, clinical trial schedule management, monitoring, data management, statistical analysis, CSR, and GCP audits.

An equally valuable differentiator is our being a smaller organization managed by a strong team of industry and InCROM experienced experts, which enables us to offer clients with a high level of flexibility and responsiveness to any urgent and/or irregular scheduling or other needs. We also contract with partners to offer clinical trial services and solutions, as well as offer on-demand and/or functional service solutions.

Key Strengths

• Extensive experience in clinical pharmacology
• High level of flexibility and responsiveness
• Service speed and quality

InCROM Group Experience

Below is a list of InCROM supported clinical trials (majority conducted at Heishinkai Medical Corporation sites)

(As of June 1, 2023)

*MO: monitoring, DM: data management, ST: statistical analysis, MW: medical writing